DAY 1

DAY 2

Speakers 2025

PROGRAM

2 DAYS OF HIGH LEVEL CONFERENCES

The Innovative Therapies Days will make the connection between the academic and the industrial worlds: from research, to clinical trials, to industrialisation.

WEDNESDAY, OCTOBER 08TH

17:00-21:00 : WELCOME EVENING & POSTER SESSION 

Poster session & foodtruck

Thursday, October 09th

8:30 : REGISTRATION AND WELCOME COFFEE

9:00 : WELCOME ADRESS

Dr Sylvain Perruche, Med’Inn’Pharma, Besançon, FR
Renaud Gaudillière, PMT director

 

09:15 : KEYNOTE
Dr Rach Fayad, KPMG, Zurich, CH

 

9:45 – 12:00 : SESSION #1 « RESEARCH TO PROOF OF CONCEPT »
Chairpersons : Pr John De Vos, CHU Montpellier and xx, FR

 

09:45 : Engineering iPSC-derived immune cells
Dr Sjoukje van der Stegen, Chan Zuckerberg BioHub, New-York, USA

 

10:15 : GOLD SPONSOR SMALL TALK

 

10:20 : BREAK – EXHIBITION HALL

 

11:00 : CeBBOc: a case study in Occitanie in building a regional cell-based biotherapy ecosystem
Pr John De Vos, CHU Montpellier, FRA

 

11:10 : Extracellular vesicles from iPSC-derived MSCs : An innovative biotherapy for osteoarthritis?
Pr Danièle Noël, IRMB, Montpellier, FRA

 

11:40 : From spontaneous regeneration to cellular engineering: towards iChondrocyte therapy of articular cartilage
Dr Farida Djouad, IRMB, Montpellier, FRA

 

12:10-14:00 : LUNCH

13:00-14:40 : EXHIBITION HALL – B2B MEETINGS

 

14:15-14:45 : SYMPOSIUM CYTIVA

 

14:45-17:30 : SESSION #2 « PROOF OF CONCEPT TO CLINIC »

Chairpersons : Dr Jessica Gobbo, CTM Inserm Dijon and xx, FR

 

14:45 : SGC off-the-shelf innovative immunotherapy to treat cancer : from bench to bedside
Dr George Alzeeb, Brenus Pharma, Lyon, FRA

 

15:15 : Biotherapies based on extracellular vesicles: from research to innovation
Dr Amanda Silva-Brun, CNRS Université Paris Cité, Paris, FRA

 

15:45 : GOLD SPONSOR SMALL TALK

15:50 : BREAK – EXHIBITION HALL

 

16:30 : Nonclinical development of in vivo CAR-T for autoimmune diseases
Dr Ana Bejanariu, Sanofi, Paris, FRA

 

17:00 : From Bench to Bedside: Regulatory Strategies and Development Tools to Streamline the Transition from Non-
Clinical to Clinical for Emerging Biotechs

PharmD Damia Benchabane, Alira Health, Paris, FRA

 

17:40-19:30 : B2B MEETINGS OR VISIT OF BESANÇON

 

19:30 : COCKTAIL & EVENING RECEPTION

Opening by representative of the President of Grand Besançon Métropole & representative of the President of the Bourgogne
Franche Comté Region
(on registration only)

Friday, October 10th

8:30 :  WELCOME COFFEE  (KURSAAL)

 

 

9:15-12:00 :  SESSION #3 : Early-Stage Clinical Trials

Chairpersons : Dr Sylvain Perruche, Med’Inn’Pharma and xx, FR 

 

09:15 : CAR-T cell in autoimmune diseases: from the laboratory to clinical applications 

Pr Dominique Farge-Bancel, CRMR MATHEC, Hôpital St-Louis, AP-HP, Université Paris Cité, Paris, FR

 

09:45 : Translating MSC Exosome Science into Therapy: Preclinical Evidence and First-in-Human Trial for Psoriasis

Pr Sai Kiang Lim, Paracrine Therapeutics, Singapour

 

10:15 : BREAK- EXHIBITION HALL

 

11:00 : The challenges of translating Pluripotent Stem Cell-derived therapies compared to somatic cell therapies: from starting material to product purity

Dr Jo Mountford, Scottish National Blood Transfusion Service, Edinburgh, UK

 

11:30 : ATMP regulation in the USA: how does it differ from the EU?

Pr Erika Lietzan, University of Missouri-Columbia, Columbia, USA

 

12:00-14:00 : LUNCH & Exhibition Hall

12:40-14:00 : B2B MEETINGS

 

14:00-16:30 : SESSION #4 : SCALE-UP AND GO TO MARKET

Chairpersons : Dr Christophe Ferrand and Dr Marina Deschamps, Right Institute, Besançon, FR

 

14:00 : Journey of India’s First Indigenous CAR-T Therapy

Dr Rahul Purwar, ImmunoACT, Bombay, India

 

14:30 :  Upcoming title (Innovation for scalable CAR-T production)

Guillaume Wallart, Cellquest, Besançon, FRA

 

15:00 : BREAK- EXHIBITION HALL

 

15:30 : ATMP release : from phase I to commercial stage

Dr Hélène Nègre, Cell For Cure by Seqens, Les Ulis, FRA

 

16:00 : CAR-T therapy for adult ALL: opportunities and challenges

Dr Claire Roddie, Autolus, London, UK

 

16:45-16:50 : CONCLUSION & END OF CONGRESS

Dr Marina Deschamps, RIGHT Institute, Besançon, FR

Renaud Gaudillière, PMT director 

Join us and meet our speakers

Dr Marina DESCHAMPS, Right Institute (Besançon, FR) – Dr Christophe FERRAND, Right Institute (Besançon, FR) – Sylvain PERRUCHE, MedInn Pharma (Besançon, FR) – Dr Martin Pule, UCL Cancer Institute & Autolus (London, UK) – Pr John De Vos, CHU Montpellier (Montpellier, FR) – Dr Sjoukje van der Stegen, Chan Zuckerberg BioHub (New-York, USA) – Pr Danièle Noël, IRMB (Montpellier, FRA) – Dr Farida Djouad, IRMB (Montpellier, FRA) – Dr Jessica Gobbo, CTM Inserm (Dijon, FR) – Dr John Maher, King’s College & Leucid Bio (London, UK) – Dr Amanda Silva-Brun, CNRS Université Paris Cité (Paris, FR) – PharmD Damia Benchabane, Alira Health, (Paris, FR) – Pr Dominique Farge-Bancel, CRMR MATHEC, Hôpital St-Louis, AP-HP, Université Paris Cité (Paris, FR) – Pr Sai Kiang Lim, Paracrine Therapeutics (Singapour) – Dr. Rahul Purwar, ImmunoACT (Bombay, India) – Dr Jo Mountford, Scottish National Blood Transfusion Service (Edinburgh, UK)

SPEAKERS